- Home
- OCG vs AIFF Comparison
OCG vs AIFF Comparison
Compare OCG & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCG
- AIFF
- Stock Information
- Founded
- OCG 2018
- AIFF 2006
- Country
- OCG Hong Kong
- AIFF United States
- Employees
- OCG N/A
- AIFF N/A
- Industry
- OCG Other Consumer Services
- AIFF
- Sector
- OCG Consumer Discretionary
- AIFF
- Exchange
- OCG Nasdaq
- AIFF NYSE
- Market Cap
- OCG 130.5M
- AIFF 37.9M
- IPO Year
- OCG 2020
- AIFF N/A
- Fundamental
- Price
- OCG $6.11
- AIFF $3.02
- Analyst Decision
- OCG
- AIFF
- Analyst Count
- OCG 0
- AIFF 0
- Target Price
- OCG N/A
- AIFF N/A
- AVG Volume (30 Days)
- OCG 9.7K
- AIFF 1.6M
- Earning Date
- OCG 07-22-2025
- AIFF 08-18-2025
- Dividend Yield
- OCG N/A
- AIFF N/A
- EPS Growth
- OCG N/A
- AIFF N/A
- EPS
- OCG N/A
- AIFF N/A
- Revenue
- OCG $622,690.00
- AIFF $139,000.00
- Revenue This Year
- OCG N/A
- AIFF N/A
- Revenue Next Year
- OCG N/A
- AIFF N/A
- P/E Ratio
- OCG N/A
- AIFF N/A
- Revenue Growth
- OCG N/A
- AIFF N/A
- 52 Week Low
- OCG $1.01
- AIFF $1.86
- 52 Week High
- OCG $7.47
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- OCG 52.40
- AIFF 48.93
- Support Level
- OCG $6.00
- AIFF $2.93
- Resistance Level
- OCG $6.30
- AIFF $3.24
- Average True Range (ATR)
- OCG 0.43
- AIFF 0.25
- MACD
- OCG -0.02
- AIFF 0.03
- Stochastic Oscillator
- OCG 67.27
- AIFF 30.84
About OCG Oriental Culture Holding LTD
Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance services to customers. The company operates through one segment, namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.